Rupert Egensperger

4.4k total citations
76 papers, 3.3k citations indexed

About

Rupert Egensperger is a scholar working on Molecular Biology, Genetics and Neurology. According to data from OpenAlex, Rupert Egensperger has authored 76 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 22 papers in Genetics and 21 papers in Neurology. Recurrent topics in Rupert Egensperger's work include Glioma Diagnosis and Treatment (22 papers), Alzheimer's disease research and treatments (18 papers) and Mitochondrial Function and Pathology (11 papers). Rupert Egensperger is often cited by papers focused on Glioma Diagnosis and Treatment (22 papers), Alzheimer's disease research and treatments (18 papers) and Mitochondrial Function and Pathology (11 papers). Rupert Egensperger collaborates with scholars based in Germany, United States and Austria. Rupert Egensperger's co-authors include Manuel B. Graeber, Siegfried Kösel, Thorsten Müller, Ulrich V. Eitzen, Katrin Marcus, H. Holländer, Helmut E. Meyer, Niklas Thon, P. Mehraein and Juliani Maslim and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Neurology.

In The Last Decade

Rupert Egensperger

75 papers receiving 3.2k citations

Peers

Rupert Egensperger
Rupert Egensperger
Citations per year, relative to Rupert Egensperger Rupert Egensperger (= 1×) peers Claude‐Alain Maurage

Countries citing papers authored by Rupert Egensperger

Since Specialization
Citations

This map shows the geographic impact of Rupert Egensperger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rupert Egensperger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rupert Egensperger more than expected).

Fields of papers citing papers by Rupert Egensperger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rupert Egensperger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rupert Egensperger. The network helps show where Rupert Egensperger may publish in the future.

Co-authorship network of co-authors of Rupert Egensperger

This figure shows the co-authorship network connecting the top 25 collaborators of Rupert Egensperger. A scholar is included among the top collaborators of Rupert Egensperger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rupert Egensperger. Rupert Egensperger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weller, Jonathan, Stefanie Quach, Rupert Egensperger, et al.. (2022). Limited efficacy of temozolomide alone for astrocytoma, IDH-mutant, CNS WHO grades 2 or 3. Journal of Neuro-Oncology. 160(1). 149–158. 5 indexed citations
2.
Biczok, Annamaria, Philipp Karschnia, Markus Lenski, et al.. (2021). Past medical history of tumors other than meningioma is a negative prognostic factor for tumor recurrence in meningiomas WHO grade I. Acta Neurochirurgica. 163(10). 2853–2859. 3 indexed citations
3.
Siller, Sebastian, Rupert Egensperger, Andrea Szelényi, et al.. (2020). Intraspinal epidermoid and dermoid cysts—tumor resection with multimodal intraoperative neurophysiological monitoring and long-term outcome. Acta Neurochirurgica. 162(11). 2895–2903. 4 indexed citations
4.
Kreth, Simone, Elisabeth Limbeck, Ludwig Christian Hinske, et al.. (2013). In human glioblastomas transcript elongation by alternative polyadenylation and miRNA targeting is a potent mechanism of MGMT silencing. Acta Neuropathologica. 125(5). 671–681. 71 indexed citations
5.
Jansen, Nathalie, Christoph Schwartz, Vera Graute, et al.. (2012). Prediction of oligodendroglial histology and LOH 1p/19q using dynamic [18F]FET-PET imaging in intracranial WHO grade II and III gliomas. Neuro-Oncology. 14(12). 1473–1480. 85 indexed citations
6.
Müller, Thorsten, Christina Looße, Anke Schnabel, et al.. (2011). The AICD Interacting Protein DAB1 is Up-Regulated in Alzheimer Frontal Cortex Brain Samples and Causes Deregulation of Proteins Involved in Gene Expression Changes. Current Alzheimer Research. 8(5). 573–582. 21 indexed citations
7.
Kögel, Donat, Caoimhín G. Concannon, Thorsten Müller, et al.. (2011). The APP intracellular domain (AICD) potentiates ER stress-induced apoptosis. Neurobiology of Aging. 33(9). 2200–2209. 34 indexed citations
8.
Eigenbrod, Sabina, Sigrun Roeber, Niklas Thon, et al.. (2011). α-Internexin in the Diagnosis of Oligodendroglial Tumors and Association With 1p/19q Status. Journal of Neuropathology & Experimental Neurology. 70(11). 970–978. 17 indexed citations
9.
Grabellus, Florian, Margarethe Konik, Karl Worm, et al.. (2010). MET overexpressing chordomas frequently exhibit polysomy of chromosome 7 but no MET activation through sarcoma-specific gene fusions. Tumor Biology. 31(3). 157–163. 13 indexed citations
10.
Hindy, Nicolai El, Michael Adamzik, Hagen S. Bachmann, et al.. (2010). Association of the GNB3 825T-allele with better survival in patients with glioblastoma multiforme. Journal of Cancer Research and Clinical Oncology. 136(9). 1423–1429. 7 indexed citations
11.
Gierga, K., Helenius J. Schelhaas, E. R. Brunt, et al.. (2009). Spinocerebellar ataxia type 6 (SCA6): neurodegeneration goes beyond the known brain predilection sites. Neuropathology and Applied Neurobiology. 35(5). 515–527. 36 indexed citations
12.
Müller, Thorsten, Helmut E. Meyer, Rupert Egensperger, & Katrin Marcus. (2008). The amyloid precursor protein intracellular domain (AICD) as modulator of gene expression, apoptosis, and cytoskeletal dynamics—Relevance for Alzheimer's disease. Progress in Neurobiology. 85(4). 393–406. 198 indexed citations
13.
Müller, Thorsten, Caoimhín G. Concannon, Manus W. Ward, et al.. (2006). Modulation of Gene Expression and Cytoskeletal Dynamics by the Amyloid Precursor Protein Intracellular Domain (AICD). Molecular Biology of the Cell. 18(1). 201–210. 114 indexed citations
14.
Reusche, E., P. Pilz, G. Oberascher, et al.. (2001). Subacute fatal aluminum encephalopathy after reconstructive otoneurosurgery: A case report. Human Pathology. 32(10). 1136–1140. 67 indexed citations
15.
Bayer, Thomas A., Pekka Jäkälä, Tobias Hartmann, et al.. (1999). Neural expression profile of α-synuclein in developing human cortex. Neuroreport. 10(13). 2799–2803. 53 indexed citations
16.
Egensperger, Rupert, Siegfried Kösel, Ulrich V. Eitzen, & Manuel B. Graeber. (1998). Microglial Activation in Alzheimer Disease: Association with APOE Genotype. Brain Pathology. 8(3). 439–447. 126 indexed citations
17.
Kösel, Siegfried, Rupert Egensperger, Ulrich V. Eitzen, Parviz Mehraein, & Manuel B. Graeber. (1997). On the question of apoptosis in the parkinsonian substantia nigra. Acta Neuropathologica. 93(2). 105–108. 113 indexed citations
18.
Bancher, C., Rupert Egensperger, Siegfried Kösel, K. A. Jellinger, & Manuel B. Graeber. (1997). Low prevalence of apolipoprotein E ε4 allele in the neurofibrillary tangle predominant form of senile dementia. Acta Neuropathologica. 94(5). 403–409. 59 indexed citations
19.
Graeber, Manuel B., Siegfried Kösel, Rupert Egensperger, et al.. (1997). Rediscovery of the case described by Alois Alzheimer in 1911: historical, histological and molecular genetic analysis. Neurogenetics. 1(1). 73–80. 112 indexed citations
20.
Kösel, Siegfried, Rupert Egensperger, P. Mehraein, & Manuel B. Graeber. (1994). No Association of Mutations at Nucleotide 5460 of Mitochondrial NADH Dehydrogenase with Alzheimer′s Disease. Biochemical and Biophysical Research Communications. 203(2). 745–749. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026